Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin

Abstract Chrysin has been shown to exert several beneficial pharmacological activities. Chrysin has anti-cancer, anti-viral, anti-diabetic, neuroprotective, cardioprotective, hepatoprotective, and renoprotective as well as gastrointestinal, respiratory, reproductive, ocular, and skin protective effe...

Full description

Bibliographic Details
Main Authors: Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, Jesus Simal-Gandara, Dalia M. Kopustinskiene, Jurga Bernatoniene, Saeed Samarghandian
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-021-01906-y
_version_ 1819087639507107840
author Marjan Talebi
Mohsen Talebi
Tahereh Farkhondeh
Jesus Simal-Gandara
Dalia M. Kopustinskiene
Jurga Bernatoniene
Saeed Samarghandian
author_facet Marjan Talebi
Mohsen Talebi
Tahereh Farkhondeh
Jesus Simal-Gandara
Dalia M. Kopustinskiene
Jurga Bernatoniene
Saeed Samarghandian
author_sort Marjan Talebi
collection DOAJ
description Abstract Chrysin has been shown to exert several beneficial pharmacological activities. Chrysin has anti-cancer, anti-viral, anti-diabetic, neuroprotective, cardioprotective, hepatoprotective, and renoprotective as well as gastrointestinal, respiratory, reproductive, ocular, and skin protective effects through modulating signaling pathway involved in apoptosis, oxidative stress, and inflammation. In the current review, we discussed the emerging cellular and molecular mechanisms underlying therapeutic indications of chrysin in various cancers. Online databases comprising Scopus, PubMed, Embase, ProQuest, Science Direct, Web of Science, and the search engine Google Scholar were searched for available and eligible research articles. The search was conducted by using MeSH terms and keywords in title, abstract, and keywords. In conclusion, experimental studies indicated that chrysin could ameliorate cancers of the breast, gastrointestinal tract, liver and hepatocytes, bladder, male and female reproductive systems, choroid, respiratory tract, thyroid, skin, eye, brain, blood cells, leukemia, osteoblast, and lymph. However, more studies are needed to enhance the bioavailability of chrysin and evaluate this agent in clinical trial studies. Graphic abstract
first_indexed 2024-12-21T21:39:21Z
format Article
id doaj.art-488061fb25dc4d09b59186582dc348c4
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-21T21:39:21Z
publishDate 2021-04-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-488061fb25dc4d09b59186582dc348c42022-12-21T18:49:24ZengBMCCancer Cell International1475-28672021-04-0121112010.1186/s12935-021-01906-yEmerging cellular and molecular mechanisms underlying anticancer indications of chrysinMarjan Talebi0Mohsen Talebi1Tahereh Farkhondeh2Jesus Simal-Gandara3Dalia M. Kopustinskiene4Jurga Bernatoniene5Saeed Samarghandian6Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical SciencesDepartment of Chemistry and Biochemistry, University of Texas at ArlingtonCardiovscular Diseases Research Center, Birjand University of Medical SciencesNutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Science, University of Vigo, Ourense CampusInstitute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health SciencesInstitute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health SciencesNoncommunicable Diseases Research Center, Neyshabur University of Medical SciencesAbstract Chrysin has been shown to exert several beneficial pharmacological activities. Chrysin has anti-cancer, anti-viral, anti-diabetic, neuroprotective, cardioprotective, hepatoprotective, and renoprotective as well as gastrointestinal, respiratory, reproductive, ocular, and skin protective effects through modulating signaling pathway involved in apoptosis, oxidative stress, and inflammation. In the current review, we discussed the emerging cellular and molecular mechanisms underlying therapeutic indications of chrysin in various cancers. Online databases comprising Scopus, PubMed, Embase, ProQuest, Science Direct, Web of Science, and the search engine Google Scholar were searched for available and eligible research articles. The search was conducted by using MeSH terms and keywords in title, abstract, and keywords. In conclusion, experimental studies indicated that chrysin could ameliorate cancers of the breast, gastrointestinal tract, liver and hepatocytes, bladder, male and female reproductive systems, choroid, respiratory tract, thyroid, skin, eye, brain, blood cells, leukemia, osteoblast, and lymph. However, more studies are needed to enhance the bioavailability of chrysin and evaluate this agent in clinical trial studies. Graphic abstracthttps://doi.org/10.1186/s12935-021-01906-yChrysinFlavonoidsOxidative stressInflammationApoptosisMetastasis
spellingShingle Marjan Talebi
Mohsen Talebi
Tahereh Farkhondeh
Jesus Simal-Gandara
Dalia M. Kopustinskiene
Jurga Bernatoniene
Saeed Samarghandian
Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
Cancer Cell International
Chrysin
Flavonoids
Oxidative stress
Inflammation
Apoptosis
Metastasis
title Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
title_full Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
title_fullStr Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
title_full_unstemmed Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
title_short Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
title_sort emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
topic Chrysin
Flavonoids
Oxidative stress
Inflammation
Apoptosis
Metastasis
url https://doi.org/10.1186/s12935-021-01906-y
work_keys_str_mv AT marjantalebi emergingcellularandmolecularmechanismsunderlyinganticancerindicationsofchrysin
AT mohsentalebi emergingcellularandmolecularmechanismsunderlyinganticancerindicationsofchrysin
AT taherehfarkhondeh emergingcellularandmolecularmechanismsunderlyinganticancerindicationsofchrysin
AT jesussimalgandara emergingcellularandmolecularmechanismsunderlyinganticancerindicationsofchrysin
AT daliamkopustinskiene emergingcellularandmolecularmechanismsunderlyinganticancerindicationsofchrysin
AT jurgabernatoniene emergingcellularandmolecularmechanismsunderlyinganticancerindicationsofchrysin
AT saeedsamarghandian emergingcellularandmolecularmechanismsunderlyinganticancerindicationsofchrysin